B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification

European Journal of Neurology

Volumn 21, Issue 6, 2014, Pages 914-921

  Kara, K ^a   Gronewold, J ^a   Neumann, T ^a   Mahabadi, A A ^a   Weimar, C ^a   Lehmann, N ^b   Berger, K ^c   Kalsch H I M ^a   Bauer, M ^a   Broecker Preuss, M ^a   Mohlenkamp S ^d   Moebus, S ^b   Jockel K H ^b   Erbel, R ^a   Hermann, D M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Department of Cardiology Hospital Bethanien Moers   (Germany)

Author keywords

Brain natriuretic peptide; Coronary calcium; Risk prediction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART VALVE SURGERY; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; AGE; BLOOD; CALCINOSIS; CORONARY ARTERY DISEASE; INCIDENCE; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR; SEX DIFFERENCE; STROKE;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CALCINOSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; STROKE;

EID: 84899947387     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12411     Document Type: Article

References (24)

1. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
2. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
3. Hildebrandt P, Collinson PO, Doughty RN, et al. Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 2010; 31: 1881-1889.
4. Gupta S, Rohatgi A, Ayers CR, et al. Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure. Am Heart J 2011; 161: 923-930.
5. Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105-1107.
6. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995; 92: 1558-1564.
7. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
8. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663.
9. Nakamura M, Tanaka F, Takahashi T, et al. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease. Am J Cardiol 2011; 108: 1564-1569.
10. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001; 32: 2559-2566.
11. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics update 2012: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
12. Pikula A, Beiser AS, DeCarli C, et al. Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study. Circulation 2012; 125: 2100-2107.
13. Takahashi T, Nakamura M, Onoda T, et al. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis 2009; 207: 298-303.
14. Fonseca AC, Brito D, Pinho E, et al. N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients. Int J Stroke 2013; doi: 10.1111/ijs.12126 [Epub ahead of print].
15. Rodríguez-Yáñez M, Arias-Rivas S, Santamaría-Cadavid M, et al. High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke. Neurology 2013; 81: 444-447.
16. Hermann DM, Gronewold J, Lehmann N, et al. Coronary artery calcification is an independent stroke predictor in the general population. Stroke 2013; 44: 1008-1013.
17. Erbel R, Möhlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56: 1397-1406.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
19. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003; 289: 2560-2572.
20. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
21. United Nations Educational, Scientific and Cultural Organization. International Standard Classification of Education. Paris, United Nations Educational, Scientific and Cultural Organization, 1997.
22. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
23. Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008; 39: 2280-2287.
24. Berger K, Kase C, Buring J. Interobserver agreement in the classification of stroke in the Physicians' Health study. Stroke 1996; 27: 238-242.